Rating Change
BMO Capital analysts downgraded Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) from Outperform to Market Perform on August 19, 2026.
downgradeNASDAQ:IONS
Ionis Pharmaceuticals, Inc. (IONS) Downgraded to Market Perform by BMO Capital
BMO Capital analysts downgraded Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) from Outperform to Market Perform on August 19, 2026.
At publication ·
What changed
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) · downgrade
- Firm
- BMO Capital
- Rating
- Outperform to Market Perform
- Price at event
- $61.25
- Market capitalization
- $12.6B
At a glance
Key takeaways
- BMO Capital downgraded Ionis Pharmaceuticals from Outperform to Market Perform on August 19, 2026, though the specific reasoning for the downgrade was not disclosed.
Market Context
Ionis Pharmaceuticals, Inc. operates in the Healthcare sector. The stock currently trades at $61.25 with a market capitalization of $12.6B. The stock has gained 37.9% over the past 52 weeks.
Analyst downgrades can weigh on a stock in the short term as institutional investors who follow BMO Capital's research adjust their positions. However, downgrades also sometimes create buying opportunities if the market overreacts to the rating change. The reasoning behind the downgrade matters more than the rating itself.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Ionis Pharmaceuticals, Inc.
Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 19, 2026 | BMO Capital | Market Perform | N/A |
| Aug 03, 2026 | JP Morgan | Overweight | N/A |
| Jul 30, 2026 | Wells Fargo | Overweight | N/A |
| Jul 30, 2026 | HC Wainwright & Co. | Buy | N/A |
| Jul 21, 2026 | Guggenheim | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View IONS Stock Page
Frequently Asked Questions
What does the Market Perform rating mean for IONS?
A rating of Market Perform from BMO Capital reflects the analyst's outlook on Ionis Pharmaceuticals, Inc. (NASDAQ:IONS). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the IONS forecast page.